No black box warning on record for Maraviroc

As of the latest FDA labeling reviewed, Maraviroc (MARAVIROC) does not carry a black box warning. Standard warnings and precautions still apply — see the full Maraviroc medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hepatotoxicity accompanied by severe rash or systemic allergic reaction, including potentially life-threatening events, has been reported. Hepatic laboratory parameters including ALT, AST, and bilirubin should be obtained prior to starting maraviroc tablets and at other time points during treatment as clinically indicated. If rash or symptoms or signs of hepatitis or a

No black box warning on record for Maraviroc

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hepatotoxicity accompanied by severe rash or systemic allergic reaction, including potentially life-threatening events, has been reported. Hepatic laboratory parameters including ALT, AST, and bilirubin should be obtained prior to starting maraviroc tablets and at other time points during treatment as clinically indicated. If rash or symptoms or signs of hepatitis or a

Maraviroc Black Box Warning

No black box warning on record for Maraviroc

Other warnings & precautions

Maraviroc Black Box Warning

No black box warning on record for Maraviroc

Other warnings & precautions